Next Article in Journal
Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan
Previous Article in Journal
Modified Liuwei Dihuang Decoction Ameliorates Oligoasthenozoospermia in Mice via Modulation of the PI3K/AKT/Nrf2 Signaling Pathway
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 9
10.3390/ph18091367
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2023, 16(3), 473.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Tan et al. FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro. Pharmaceuticals 2023, 16, 473

by
Yanlin Tan
1,2,
Xiaobin Wang
2,
Yi Zhang
2,
Zhehao Dai
2,
Jing Li
2,
Chuning Dong
1,
Xingwang Yao
3,
Chang Lu
2 and
Fei Chen
2,*
1
Department of Nuclear Medicine, The Second Xiangya Hospital of Central South University, Changsha 410011, China
2
Department of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China
3
Department of Surgery Room, The Second Xiangya Hospital of Central South University, Changsha 410011, China
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(9), 1367; https://doi.org/10.3390/ph18091367
Submission received: 20 August 2025 / Accepted: 27 August 2025 / Published: 12 September 2025
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in “Knockdown of miR-9-5p suppresses apoptosis and ECM degradation by targeting BMP2 in NP cells. (A) MiR-9-5p expression by qPCR. (B) BMP2 expression by qPCR and Western blot. (C) Cell viability by CCK-8 assay. (D) Apoptosis in NP cells by flow cytometry. (E,F) Expressions of ECM proteins by Western blot (E) and immunofluorescence (F). Data were estimated as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001” as published, in which the plot of the control group is duplicated from Figure 2D in the work of Wu et al., 2022 [2]. Upon thorough investigation, this error resulted from erroneous provision of image materials by a third-party collaborator. The corrected Figure 7D appears below. With this correction, the plot of the control group in Figure 7D has been replaced with a new plot. All authors apologize for this error. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Tan, Y.; Wang, X.; Zhang, Y.; Dai, Z.; Li, J.; Dong, C.; Yao, X.; Lu, C.; Chen, F. FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro. Pharmaceuticals 2023, 16, 473. [Google Scholar] [CrossRef]
  2. Wu, R.; Yun, Q.; Zhang, J.; Wang, Z.; Zhang, X.; Bao, J. Knockdown of circular RNA tousled-like kinase 1 relieves ischemic stroke in middle cerebral artery occlusion mice and oxygen-glucose deprivation and reoxygenation-induced N2a cell damage. Bioengineered 2022, 13, 3434–3449. [Google Scholar] [CrossRef] [PubMed]
Pharmaceuticals 18 01367 g007
Figure 7. Knockdown of miR-9-5p suppresses apoptosis and ECM degradation by targeting BMP2 in NP cells. (A) MiR-9-5p expression by qPCR. (B) BMP2 expression by qPCR and Western blot. (C) Cell viability by CCK-8 assay. (D) Apoptosis in NP cells by flow cytometry. (E,F) Expressions of ECM proteins and apoptosis-related proteins by Western blot (E) and immunofluorescence (F). Data were estimated as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 7. Knockdown of miR-9-5p suppresses apoptosis and ECM degradation by targeting BMP2 in NP cells. (A) MiR-9-5p expression by qPCR. (B) BMP2 expression by qPCR and Western blot. (C) Cell viability by CCK-8 assay. (D) Apoptosis in NP cells by flow cytometry. (E,F) Expressions of ECM proteins and apoptosis-related proteins by Western blot (E) and immunofluorescence (F). Data were estimated as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Pharmaceuticals 18 01367 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tan, Y.; Wang, X.; Zhang, Y.; Dai, Z.; Li, J.; Dong, C.; Yao, X.; Lu, C.; Chen, F. Correction: Tan et al. FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro. Pharmaceuticals 2023, 16, 473. Pharmaceuticals 2025, 18, 1367. https://doi.org/10.3390/ph18091367

AMA Style

Tan Y, Wang X, Zhang Y, Dai Z, Li J, Dong C, Yao X, Lu C, Chen F. Correction: Tan et al. FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro. Pharmaceuticals 2023, 16, 473. Pharmaceuticals. 2025; 18(9):1367. https://doi.org/10.3390/ph18091367

Chicago/Turabian Style

Tan, Yanlin, Xiaobin Wang, Yi Zhang, Zhehao Dai, Jing Li, Chuning Dong, Xingwang Yao, Chang Lu, and Fei Chen. 2025. "Correction: Tan et al. FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro. Pharmaceuticals 2023, 16, 473" Pharmaceuticals 18, no. 9: 1367. https://doi.org/10.3390/ph18091367

APA Style

Tan, Y., Wang, X., Zhang, Y., Dai, Z., Li, J., Dong, C., Yao, X., Lu, C., & Chen, F. (2025). Correction: Tan et al. FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro. Pharmaceuticals 2023, 16, 473. Pharmaceuticals, 18(9), 1367. https://doi.org/10.3390/ph18091367

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop